Data as of Oct 21
| +6.91 / +3.85%|
The 19 analysts offering 12-month price forecasts for Allergan Inc have a median target of 207.00, with a high estimate of 230.00 and a low estimate of 174.00. The median estimate represents a +11.19% increase from the last price of 186.16.
The current consensus among 23 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.